Blue-reka! Investigating Methylene Blue as a Neuroprotectant for Traumatic Brain Injury Using a Novel Drosophila Model
CSEF · 2026 Zoology (Junior Division)
Overview
Traumatic brain injury (TBI) is the leading cause of disabilities and deaths worldwide, with Americans experiencing 2.5 million hospitalizations and fatalities annually and $19B in economic losses. TBI’s physical and mental impacts decrease quality of life and increase the risk of future neurodegenerative conditions. This project investigates methylene blue’s effect on mitigating secondary injury after TBI, using Drosophila hydei as a novel in vivo treatment model. This research will increase knowledge for medical sciences about well-tolerated, affordable, and accessible neuroprotection to mitigate TBI. HYPOTHESIS: IF drosophila consume methylene blue pre- and post- traumatic brain injury, THEN it will mitigate secondary brain injury, with the highest dosage being most effective, BECAUSE methylene blue is neuroprotective, thus decreasing oxidative stress and regulating cell processes. PROCEDURE: 350 drosophila over 7 trials consumed various methylene blue dosages for 5 days, then received 3 strikes from a 90-degree retraction angle in the High-Impact Trauma (HIT) device. A 20-second climbing assay measured the number of drosophila passing a 2.5cm-high “finish line.” After 24 hours, survival counts were taken. OBSERVATIONS/DATA/RESULTS: The highest number of drosophila passing the finish line and surviving after 24 hours consumed 8 mg/kg of methylene blue. All treatment groups had higher average numbers of drosophila passing the line and surviving vs. Control. The Climbing-Survival Index (CSI) score – a novel biomarker I propose, combining immediate and delayed measures – was highest for the 8 mg/kg dosage. CONCLUSIONS: Methylene blue is neuroprotective, decreasing oxidative stress and regulating cellular processes to mitigate secondary injury. This research impacts healthcare and medical sciences, identifying a well-tolerated, affordable, and accessible neuroprotectant to improve TBI outcomes.
Competition history
- CSEF 2026
Related projects
ISEF · 2018
Methylene Blue May Mitigate Symptoms of Traumatic Brain Injury
JSHS · 2025
Fighting the Brain Injury Crisis: A Protective & Affordable Helmet
AJAS · 2020
Using Drosophila Melanogaster as an Integrated Model to Study Traumatic Brain Injury
ISEF · 2021
The Investigation of Photobiomodulation as a Factor to Impact Physical Damage, Psychological Behavior, and Metabolic Activity Following a Traumatic Brain Injury in Drosophila melanogaster
ISEF · 2022
Flies on the Fly: A Novel Research on Thiamine as a Preventative Measure to Traumatic-Brain-Injury-Induced Locomotive Ability Loss
ISEF · 2020
Staying Ahead of the Hit: Using Drosophila melanogaster as an Integrated Model to Elucidate the Neuropathology, Physiology, and Genetic Mechanisms Underlying Traumatic Brain Injury
ISEF · 2019
G-CSF as a Preventative Treatment for Traumatic Brain Injury in Drosophila melanogaster
JSHS · 2020
Using Drosophila melanogaster as an Integrated Model to Elucidate the Cellular and Genetic Mechanisms Underlying Traumatic Brain Injury (TBI)
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects